| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell-Free Nucleic Acids | 7 | 2023 | 83 | 4.300 |
Why?
|
| Computational Biology | 13 | 2018 | 551 | 3.480 |
Why?
|
| Gene Expression Profiling | 22 | 2019 | 1452 | 2.770 |
Why?
|
| Algorithms | 20 | 2018 | 1913 | 2.440 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 12 | 2011 | 693 | 2.250 |
Why?
|
| Genomics | 8 | 2015 | 778 | 1.710 |
Why?
|
| Software | 12 | 2023 | 669 | 1.670 |
Why?
|
| Databases, Genetic | 9 | 2015 | 269 | 1.660 |
Why?
|
| DNA Methylation | 8 | 2023 | 666 | 1.600 |
Why?
|
| Gene Regulatory Networks | 8 | 2015 | 310 | 1.580 |
Why?
|
| Chromatin | 8 | 2023 | 403 | 1.480 |
Why?
|
| Genome, Human | 7 | 2016 | 791 | 1.220 |
Why?
|
| Neoplasms | 8 | 2023 | 3065 | 1.140 |
Why?
|
| Protein Isoforms | 3 | 2016 | 278 | 1.000 |
Why?
|
| Genome | 6 | 2023 | 391 | 0.960 |
Why?
|
| MicroRNAs | 5 | 2014 | 556 | 0.950 |
Why?
|
| Sequence Analysis, RNA | 4 | 2015 | 241 | 0.910 |
Why?
|
| Alternative Splicing | 3 | 2016 | 212 | 0.890 |
Why?
|
| Disease | 2 | 2014 | 90 | 0.740 |
Why?
|
| Circulating Tumor DNA | 1 | 2021 | 48 | 0.710 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 528 | 0.670 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 260 | 0.660 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 1158 | 0.660 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 288 | 0.660 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 2415 | 0.660 |
Why?
|
| Epigenomics | 3 | 2017 | 103 | 0.650 |
Why?
|
| Chromosomes | 5 | 2023 | 98 | 0.650 |
Why?
|
| Phenotype | 6 | 2015 | 2456 | 0.600 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 521 | 0.590 |
Why?
|
| Chromosome Mapping | 4 | 2017 | 1074 | 0.580 |
Why?
|
| Humans | 47 | 2023 | 89961 | 0.560 |
Why?
|
| Genome-Wide Association Study | 5 | 2013 | 1691 | 0.550 |
Why?
|
| Databases, Protein | 4 | 2012 | 51 | 0.540 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 1983 | 0.540 |
Why?
|
| Models, Genetic | 5 | 2015 | 948 | 0.530 |
Why?
|
| Bayes Theorem | 3 | 2013 | 382 | 0.520 |
Why?
|
| Sepsis | 1 | 2020 | 329 | 0.510 |
Why?
|
| Gene Expression | 5 | 2015 | 1309 | 0.510 |
Why?
|
| Chromosomes, Human | 2 | 2016 | 65 | 0.510 |
Why?
|
| Linear Models | 2 | 2014 | 421 | 0.510 |
Why?
|
| Cell Physiological Phenomena | 1 | 2015 | 24 | 0.500 |
Why?
|
| Computer Simulation | 6 | 2021 | 1102 | 0.480 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2023 | 490 | 0.480 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 784 | 0.470 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 71 | 0.440 |
Why?
|
| Ovarian Neoplasms | 4 | 2014 | 772 | 0.430 |
Why?
|
| Biomarkers, Tumor | 6 | 2023 | 1545 | 0.420 |
Why?
|
| Pattern Recognition, Automated | 3 | 2010 | 221 | 0.420 |
Why?
|
| Protein Interaction Mapping | 2 | 2014 | 81 | 0.420 |
Why?
|
| Signal Transduction | 3 | 2008 | 3404 | 0.380 |
Why?
|
| Proteome | 2 | 2016 | 135 | 0.380 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2011 | 46 | 0.380 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 983 | 0.370 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 181 | 0.370 |
Why?
|
| Multifactorial Inheritance | 1 | 2013 | 173 | 0.370 |
Why?
|
| RNA Splicing | 1 | 2012 | 156 | 0.360 |
Why?
|
| DNA | 2 | 2015 | 1311 | 0.350 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 202 | 0.350 |
Why?
|
| Information Storage and Retrieval | 2 | 2010 | 121 | 0.340 |
Why?
|
| Cluster Analysis | 4 | 2012 | 371 | 0.320 |
Why?
|
| Datasets as Topic | 2 | 2021 | 75 | 0.300 |
Why?
|
| Early Detection of Cancer | 2 | 2022 | 422 | 0.300 |
Why?
|
| Fungal Proteins | 2 | 2005 | 142 | 0.290 |
Why?
|
| CpG Islands | 2 | 2018 | 158 | 0.280 |
Why?
|
| DNA, Neoplasm | 2 | 2018 | 266 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 1284 | 0.270 |
Why?
|
| Database Management Systems | 1 | 2006 | 41 | 0.270 |
Why?
|
| Biomarkers | 3 | 2023 | 1778 | 0.260 |
Why?
|
| Transcription Factors | 4 | 2017 | 1664 | 0.260 |
Why?
|
| Cell Nucleus | 3 | 2023 | 602 | 0.260 |
Why?
|
| Models, Statistical | 3 | 2017 | 576 | 0.250 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 515 | 0.250 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 869 | 0.250 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2026 | 0.240 |
Why?
|
| Data Interpretation, Statistical | 4 | 2014 | 303 | 0.240 |
Why?
|
| Data Mining | 2 | 2017 | 44 | 0.240 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2005 | 62 | 0.240 |
Why?
|
| Models, Biological | 3 | 2018 | 1766 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 3 | 2023 | 961 | 0.210 |
Why?
|
| Internet | 3 | 2014 | 323 | 0.210 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2018 | 603 | 0.210 |
Why?
|
| Likelihood Functions | 3 | 2016 | 252 | 0.200 |
Why?
|
| Animals | 15 | 2017 | 27528 | 0.200 |
Why?
|
| Extracellular Vesicles | 1 | 2023 | 42 | 0.200 |
Why?
|
| Computer Graphics | 3 | 2007 | 100 | 0.200 |
Why?
|
| Mutation | 3 | 2023 | 4168 | 0.200 |
Why?
|
| Aging | 1 | 2006 | 727 | 0.190 |
Why?
|
| Databases, Factual | 2 | 2019 | 866 | 0.190 |
Why?
|
| Methylation | 2 | 2020 | 269 | 0.190 |
Why?
|
| Exome | 1 | 2022 | 131 | 0.190 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2767 | 0.190 |
Why?
|
| Neoplasm, Residual | 1 | 2022 | 181 | 0.180 |
Why?
|
| Liquid Biopsy | 1 | 2020 | 36 | 0.180 |
Why?
|
| Heterochromatin | 2 | 2017 | 24 | 0.180 |
Why?
|
| Regression Analysis | 2 | 2012 | 591 | 0.170 |
Why?
|
| Markov Chains | 2 | 2013 | 128 | 0.170 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 173 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 467 | 0.170 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 244 | 0.160 |
Why?
|
| Repressor Proteins | 2 | 2012 | 423 | 0.160 |
Why?
|
| Centromere | 2 | 2016 | 26 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 399 | 0.160 |
Why?
|
| Cytological Techniques | 1 | 2018 | 30 | 0.150 |
Why?
|
| Cell Line | 4 | 2016 | 2495 | 0.150 |
Why?
|
| Molecular Conformation | 1 | 2018 | 96 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 663 | 0.150 |
Why?
|
| Chromosomes, Insect | 1 | 2017 | 8 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 605 | 0.140 |
Why?
|
| Biopsy | 1 | 2021 | 1184 | 0.140 |
Why?
|
| User-Computer Interface | 2 | 2010 | 187 | 0.140 |
Why?
|
| Genome, Insect | 1 | 2017 | 77 | 0.140 |
Why?
|
| Mass Screening | 1 | 2021 | 647 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 2018 | 0.140 |
Why?
|
| Female | 7 | 2021 | 46587 | 0.140 |
Why?
|
| Workflow | 1 | 2017 | 81 | 0.130 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 755 | 0.130 |
Why?
|
| Genotype | 2 | 2013 | 1852 | 0.130 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2013 | 16 | 0.130 |
Why?
|
| Artificial Intelligence | 2 | 2010 | 332 | 0.130 |
Why?
|
| Intensive Care Units | 1 | 2020 | 398 | 0.130 |
Why?
|
| Protein Interaction Maps | 2 | 2016 | 50 | 0.130 |
Why?
|
| ROC Curve | 1 | 2018 | 778 | 0.130 |
Why?
|
| Genes, Essential | 1 | 2015 | 20 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1352 | 0.130 |
Why?
|
| Bacteria | 1 | 2020 | 486 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 952 | 0.130 |
Why?
|
| Nucleosomes | 2 | 2012 | 55 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2018 | 340 | 0.120 |
Why?
|
| Chromosomes, Fungal | 1 | 2015 | 15 | 0.120 |
Why?
|
| Metagenomics | 1 | 2016 | 92 | 0.120 |
Why?
|
| Saccharomycetales | 1 | 2015 | 11 | 0.120 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2015 | 39 | 0.120 |
Why?
|
| Genome, Fungal | 1 | 2015 | 34 | 0.120 |
Why?
|
| Genomic Library | 1 | 2014 | 33 | 0.120 |
Why?
|
| Genetic Pleiotropy | 1 | 2015 | 25 | 0.120 |
Why?
|
| Drosophila melanogaster | 2 | 2017 | 614 | 0.120 |
Why?
|
| Papio | 1 | 2015 | 82 | 0.120 |
Why?
|
| Schizosaccharomyces | 1 | 2015 | 55 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2022 | 1497 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 101 | 0.120 |
Why?
|
| Forecasting | 1 | 2015 | 304 | 0.120 |
Why?
|
| RNA Isoforms | 1 | 2013 | 5 | 0.110 |
Why?
|
| Drug Therapy | 1 | 2014 | 69 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 3022 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 171 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 120 | 0.110 |
Why?
|
| Species Specificity | 2 | 2006 | 685 | 0.110 |
Why?
|
| Prognosis | 1 | 2021 | 3798 | 0.110 |
Why?
|
| Pan troglodytes | 1 | 2015 | 203 | 0.110 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 186 | 0.100 |
Why?
|
| Population Groups | 1 | 2012 | 41 | 0.100 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 41 | 0.100 |
Why?
|
| Oncogenes | 1 | 2012 | 97 | 0.100 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 99 | 0.100 |
Why?
|
| Drosophila Proteins | 2 | 2017 | 510 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1533 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 163 | 0.090 |
Why?
|
| RNA | 1 | 2015 | 583 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 95 | 0.090 |
Why?
|
| Mice | 4 | 2015 | 11851 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3024 | 0.090 |
Why?
|
| Exons | 1 | 2012 | 453 | 0.090 |
Why?
|
| Comorbidity | 1 | 2014 | 953 | 0.090 |
Why?
|
| Postmortem Changes | 1 | 2010 | 8 | 0.090 |
Why?
|
| Histones | 1 | 2012 | 333 | 0.090 |
Why?
|
| Access to Information | 1 | 2010 | 28 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2011 | 284 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2022 | 8273 | 0.080 |
Why?
|
| Unified Medical Language System | 1 | 2009 | 1 | 0.080 |
Why?
|
| Biometry | 1 | 2009 | 66 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 2370 | 0.080 |
Why?
|
| Systems Biology | 1 | 2009 | 44 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 2360 | 0.080 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2008 | 17 | 0.080 |
Why?
|
| Precision Medicine | 2 | 2022 | 413 | 0.070 |
Why?
|
| Diploidy | 2 | 2018 | 31 | 0.070 |
Why?
|
| Transcriptome | 1 | 2012 | 661 | 0.070 |
Why?
|
| Apoptosis | 1 | 2013 | 1718 | 0.070 |
Why?
|
| Systems Integration | 1 | 2006 | 36 | 0.070 |
Why?
|
| Models, Molecular | 3 | 2016 | 1315 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 440 | 0.070 |
Why?
|
| Sample Size | 1 | 2006 | 125 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2009 | 286 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2017 | 352 | 0.060 |
Why?
|
| Proteins | 1 | 2011 | 787 | 0.060 |
Why?
|
| Genes, Fungal | 1 | 2005 | 58 | 0.060 |
Why?
|
| Binding Sites | 1 | 2007 | 1121 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2005 | 234 | 0.060 |
Why?
|
| Asthma | 1 | 2012 | 984 | 0.060 |
Why?
|
| Base Sequence | 1 | 2007 | 2329 | 0.050 |
Why?
|
| Protein Binding | 1 | 2007 | 1491 | 0.050 |
Why?
|
| Glypicans | 1 | 2023 | 6 | 0.050 |
Why?
|
| Embryonic Stem Cells | 2 | 2013 | 81 | 0.050 |
Why?
|
| Polycomb-Group Proteins | 2 | 2012 | 9 | 0.050 |
Why?
|
| Middle Aged | 1 | 2021 | 26146 | 0.050 |
Why?
|
| Adult | 1 | 2021 | 26816 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2021 | 70 | 0.050 |
Why?
|
| Male | 2 | 2021 | 42674 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2023 | 497 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 4048 | 0.040 |
Why?
|
| Proteomics | 1 | 2021 | 232 | 0.040 |
Why?
|
| Circulating MicroRNA | 1 | 2019 | 13 | 0.040 |
Why?
|
| Brain | 1 | 2010 | 2305 | 0.040 |
Why?
|
| Quantitative Trait Loci | 2 | 2015 | 615 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 6783 | 0.040 |
Why?
|
| Exosomes | 1 | 2019 | 53 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2018 | 156 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 67 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 60 | 0.030 |
Why?
|
| Multigene Family | 1 | 2017 | 202 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2017 | 196 | 0.030 |
Why?
|
| Chromosome Positioning | 1 | 2016 | 3 | 0.030 |
Why?
|
| Tomography, X-Ray | 1 | 2016 | 18 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2023 | 1227 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2016 | 77 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 86 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2016 | 121 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 34 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 645 | 0.030 |
Why?
|
| Primates | 1 | 2016 | 155 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2015 | 120 | 0.030 |
Why?
|
| Telomere | 1 | 2015 | 119 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1469 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 156 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2016 | 468 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2327 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 253 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2015 | 178 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 50 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 740 | 0.030 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2012 | 10 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 727 | 0.030 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2012 | 32 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 90 | 0.030 |
Why?
|
| Aged | 1 | 2010 | 19254 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 154 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2012 | 78 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 137 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2012 | 203 | 0.020 |
Why?
|
| Azacitidine | 1 | 2013 | 147 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2011 | 16 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 178 | 0.020 |
Why?
|
| Lysine | 1 | 2012 | 152 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2015 | 515 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 463 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 854 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 450 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2064 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 759 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2016 | 974 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3252 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 2586 | 0.020 |
Why?
|